{
  "docId": "019de075-e341-775b-a82c-decdaeb5c03e",
  "docSlug": "c5ed60c4cc85a094dbae2fa13cb26a34",
  "documentTitle": "Alkermes | Investor Presentation Deck | 37 slides",
  "authorId": "alkermes",
  "authorName": "Mural Oncology",
  "documentKindSlug": "conference-presentation",
  "documentKindLabel": "Conference presentation",
  "sourceTypeSlug": "investor_relations",
  "sourceTypeLabel": "Investor relations",
  "presentationDate": "2023-10-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.7777778,
  "pageNumber": 13,
  "pageCount": 37,
  "prevPage": 12,
  "nextPage": 14,
  "slideType": "comparison_table",
  "function": "compare_peers",
  "density": "balanced",
  "nDataPoints": 0,
  "notes": "Uses a before-after-framing style comparison to illustrate the mechanism of action differentiation.",
  "elementsJson": null,
  "metadataConfidence": 0.95,
  "imagePath": null,
  "slideHref": "/slides/019de075-e341-775b-a82c-decdaeb5c03e/13",
  "deckHref": "/decks/019de075-e341-775b-a82c-decdaeb5c03e",
  "deckJsonHref": "/decks/019de075-e341-775b-a82c-decdaeb5c03e.json",
  "deckAnchorHref": "/decks/019de075-e341-775b-a82c-decdaeb5c03e#slide-13",
  "components": [
    {
      "bbox": {
        "h": 0.42,
        "w": 0.94,
        "x": 0.03,
        "y": 0.5
      },
      "kind": "framework",
      "text": "Mechanism of action comparison between Nemvaleukin and IL-2",
      "attrs": null,
      "subkind": "instance",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "256cd280-a996-4fb7-845d-79fb2f212e28",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.25,
        "w": 0.56,
        "x": 0.22,
        "y": 0.22
      },
      "kind": "image",
      "text": "Molecular structure comparison of Nemvaleukin and IL-2/IL-2Ra complex",
      "attrs": null,
      "subkind": "illustration",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "8280877f-a16a-4fb6-80fb-f8965b7d89eb",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.25,
        "w": 0.18,
        "x": 0.04,
        "y": 0.235
      },
      "kind": "list",
      "text": "Intrinsically active stable fusion protein; Does not require metabolic or proteolytic conversion; Does not degrade to native IL-2",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "d72a9024-93c6-4fb1-bd4f-cbe6cd8b99e3",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.05,
        "w": 0.88,
        "x": 0.06,
        "y": 0.12
      },
      "kind": "title",
      "text": "Nemvaleukin Meaningfully Differentiated from High-Dose IL-2",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "c360c053-34aa-40e3-80c9-78fdd5aa3d8c",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [],
  "frameworks": [
    {
      "name": "before-after-framing",
      "slug": null,
      "matchId": "6df56bcd-8b16-450a-a477-155c131ddd08",
      "evidence": "The slide contrasts the mechanism of Nemvaleukin (left) with the problematic mechanism of IL-2 (right) to show differentiation.",
      "confidence": 0.9
    }
  ],
  "arcBeats": [
    {
      "to": 20,
      "from": 12,
      "beatId": "59c25a5c-9ce0-4688-9ac5-7b20dd5595fc",
      "arcName": "The Sequoia Pitch",
      "arcSlug": "sequoia-pitch",
      "beatName": "Solution",
      "beatSlug": "sequoia-pitch-solution",
      "evidence": "Slides 12-20 present Nemvaleukin alfa as a solution, including its development approach and clinical results.",
      "position": 1,
      "confidence": 0.8,
      "parentBeatName": "Turn",
      "parentBeatSlug": "turn"
    }
  ],
  "loops": [],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}